Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Iovance Biotherapeutics main competitors are Exelixis, Incyte, and Gilead Sciences.
Competitor Summary. See how Iovance Biotherapeutics compares to its main competitors:
| Company | Founding date | Zippia score | Headquarters | # of Locations | Revenue | Employees |
|---|---|---|---|---|---|---|
| 2007 | 4.2 | San Carlos, CA | 3 | $164.1M | 319 | |
| 1997 | 4.7 | Bothell, WA | 3 | $2.0B | 900 | |
| 1987 | 4.5 | Foster City, CA | 9 | $28.8B | 11,800 | |
| 1992 | 4.9 | Rockville, MD | 1 | $131.0M | 1,000 | |
| 1994 | 4.9 | Alameda, CA | 1 | $2.2B | 484 | |
| 1992 | 4.8 | Lexington, MA | 1 | $926.4M | 873 | |
| 1979 | 4.7 | San Diego, CA | 3 | $1.7B | 1,500 | |
| 1991 | 4.8 | Cambridge, MA | 1 | $118.8M | 380 | |
| 1989 | 4.6 | Boston, MA | 5 | $11.0B | 3,400 | |
| 1991 | 4.8 | Wilmington, DE | 1 | $4.2B | 1,600 | |
Alzheon | 2013 | 3.9 | Framingham, MA | 1 | $8.0M | 5 |
Rate Iovance Biotherapeutics' competitiveness in the market.
| Company | Highest salary | Hourly salary |
|---|---|---|
Iovance Biotherapeutics | $121,354 | $58.34 |
Quidel | $159,872 | $76.86 |
Exelixis | $159,472 | $76.67 |
Cubist Pharmaceuticals | $154,617 | $74.34 |
Human Genome Sciences | $147,521 | $70.92 |
Incyte | $139,084 | $66.87 |
Vertex Pharmaceuticals | $136,295 | $65.53 |
Ariad Pharmaceuticals | $136,241 | $65.50 |
Gilead Sciences | $130,710 | $62.84 |
Alzheon | $120,353 | $57.86 |
Seagen | $117,601 | $56.54 |
Do you work at Iovance Biotherapeutics?
Does Iovance Biotherapeutics effectively differentiate itself from competitors?
| Job title | Male | Female |
|---|---|---|
| Cubist Pharmaceuticals | 52% | 48% |
| Vertex Pharmaceuticals | 56% | 44% |
| Gilead Sciences | 56% | 44% |
| Quidel | 58% | 42% |
| Incyte | 59% | 41% |
| Iovance Biotherapeutics | - | - |
| Company | White | Hispanic or Latino | Black or African American | Asian | Unknown | Diversity score |
|---|---|---|---|---|---|---|
| 44% | 20% | 8% | 23% | 6% | 9.8 | |
| 53% | 11% | 9% | 22% | 5% | 9.3 | |
| 50% | 24% | 8% | 14% | 5% | 9.8 | |
| 56% | 14% | 7% | 17% | 6% | 9.7 | |
| 60% | 12% | 8% | 17% | 4% | 9.9 | |
| 58% | 9% | 7% | 22% | 5% | 9.2 |